About Syswin Pharmaceuticals Private Limited
Data last updated:
Syswin Pharmaceuticals Private Limited is a private limited company based in Bengaluru, Karnataka, India. It operates in the electronics manufacturing segment of the consumer electronics and durables sector. It was incorporated on 22 August 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24100KA2014PTC075974. Its GSTIN is 29AAUCS9403L1ZG (Karnataka).
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹30 Lakh. It is led by directors including Chitrahalli Subbarao Ramesh (Managing Director) and Anekal Venkataramaiah Sathyakeerthy.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bengaluru, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.5 Cr, a growth of 22% compared to the previous year. For the same year it recorded a net loss of ₹21.05 Lakh (net margin -2.8%) and EBITDA of -₹9.03 Lakh (EBITDA margin -1.2%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years and 8% over five years.
The company has about 50 employees on its provident fund (EPFO) records.
Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website syswinpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressNo.661 1st Floor 80 Feet Road 2nd Main 7th Block 2nd Phase Banashankari 3rd S, Tage, Bengaluru, Karnataka, India – 560085
- IndustryConsumer Electronics & Durables, Electronics Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Syswin Pharmaceuticals Private Limited
The main business activity of Syswin Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Syswin Pharmaceuticals Private Limited
Syswin Pharmaceuticals Private Limited is audited by H.R.Shenoy & Co. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| H.R.Shenoy & Co. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Syswin Pharmaceuticals Private Limited
Syswin Pharmaceuticals has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chitrahalli Subbarao Ramesh | Managing Director | 22 Aug 2014 | 12 Years 1 Months | Current |
| Anekal Venkataramaiah Sathyakeerthy | Director | 22 Aug 2014 | 12 Years 1 Months | Current |
| Benakanakere Lakshmikantha Suma | Director | 22 Aug 2014 | 12 Years 1 Months | Current |
Financials of Syswin Pharmaceuticals Private Limited FY 2025 filings available
Syswin Pharmaceuticals Private Limited reported revenue of ₹7.5 Cr (up 22% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Syswin Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 22% growth in the latest year. EBITDA rose 86% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Syswin Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹9.03 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹21.05 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Syswin Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -1.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -2.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Syswin Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Syswin Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Syswin Pharmaceuticals Private Limited
Syswin Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Syswin Pharmaceuticals Private Limited
Syswin Pharmaceuticals Private Limited has a workforce of 50 employees as of Apr 08, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Syswin Pharmaceuticals Private Limited
Syswin Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAUCS9403L1ZG | Karnataka | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Legal Cases of Syswin Pharmaceuticals Private Limited
Syswin Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is disposed. Status as checked on 30 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, West, Delhi | Court case (TM) | Filed against the company by Systopic Laboratories Private Limited | Disposed |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit Ratings, Litigation & Regulatory Alerts for Syswin Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Syswin Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Syswin Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Syswin Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Syswin Pharmaceuticals Private Limited
Frequently Asked Questions about Syswin Pharmaceuticals Private Limited
Syswin Pharmaceuticals is an active private limited company based in Bengaluru, Karnataka, India. The company works in electronics manufacturing, within the consumer electronics and durables industry. It was incorporated on 22 August 2014 (12+ years old) and is registered under CIN U24100KA2014PTC075974.
Syswin Pharmaceuticals reported revenue of ₹7.5 Cr for FY 2025 (up 22% YoY).
Syswin Pharmaceuticals has 3 current directors:
- Chitrahalli Subbarao Ramesh - Managing Director
- Anekal Venkataramaiah Sathyakeerthy - Director
- Benakanakere Lakshmikantha Suma - Director
Syswin Pharmaceuticals reported a net loss of ₹21.05 Lakh (net margin -2.8%) and EBITDA of -₹9.03 Lakh (EBITDA margin -1.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Syswin Pharmaceuticals is 17% over three years and 8% over five years. In the latest year (FY 2025) revenue rose 22%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Syswin Pharmaceuticals is 29AAUCS9403L1ZG, registered in Karnataka.
The CIN (Corporate Identification Number) of Syswin Pharmaceuticals is U24100KA2014PTC075974. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Syswin Pharmaceuticals has 1 court case on record: 1 filed against it.
Syswin Pharmaceuticals was incorporated on 22 August 2014, making it 12+ years old. It is registered with the Registrar of Companies, Bangalore.